一个虚拟招聘协议促进了代表性不足的群体在糖尿病预防试验中的招生
Natalie D Ritchie1,2, Melanie T Turk3, Jodi Summers Holtrop4,5
1Center for Health Systems Research, Denver Health and Hospital Authority, Denver, CO, USA.
Journal of clinical and translational science
|February 22, 2024
概括
远程糖尿病研究协议显著增加了入学率,特别是在代表性不足的群体. 这种方法增强了不同人群在临床试验中的参与.
科学领域:
- 临床试验 临床试验
- 糖尿病研究 糖尿病研究
- 健康 公平 卫生 公平
背景情况:
- 代表性不足的群体面临参与糖尿病研究的障碍.
- 临床试验的招生往往有利于面对面的协议,限制了多样性.
- 新的战略对于扩大参与健康研究至关重要.
研究的目的:
- 评估远程研究协议对糖尿病研究入学人数的影响.
- 评估远程设计在招募多样化的患者群体中的有效性.
- 为了比较远程和实体临床试验协议之间的入学率.
主要方法:
- 在安全网医疗保健系统中招募2807名不同患者.
- 在NDPP前临床试验中使用了远程研究协议.
- 分析了招生数据,比较了远程与面对面的参与.
主要成果:
- 远程协议显示录取的几率增加了三倍 (AOR 2.90,P < 0.001).
- 在拉丁人和黑人,西班牙语说者,以及那些有医疗补助或无保险身份的人群中观察到更高的入学率.
- 远程设计促进了优先人群的参与.
结论:
- 远程研究设计可以显著提高整体临床试验招聘率.
- 实施远程协议是一种有效的策略,可以提高在糖尿病研究中代表性不足的群体的入学率.
- 这种方法通过增加不同人群获得临床研究的机会来促进健康公平.
更多相关视频
相关概念视频
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32


